Emergent wins $235.8m US defence contract for Anthrax vaccine
The US Department of Defense procurement contract for Emergent’s BioThrax is comprised of an initial five-year base agreement.
The US Department of Defense procurement contract for Emergent’s BioThrax is comprised of an initial five-year base agreement.
What's Your Reaction?
